A healthy dose of sound nutrition science

By ACSH Staff — Dec 30, 2011
As one ACSH staffer has remarked, Dr. Keith Ayoob s nutrition articles in USA Today are a breath of fresh air. Dr. Ayoob is a dietitian and associate clinical professor of pediatrics at the Albert Einstein College of Medicine in New York City.

As one ACSH staffer has remarked, Dr. Keith Ayoob s nutrition articles in USA Today are a breath of fresh air. Dr. Ayoob is a dietitian and associate clinical professor of pediatrics at the Albert Einstein College of Medicine in New York City.

New York, New York: Great place to live longer!

By ACSH Staff — Dec 29, 2011
Some good news for residents of the Big Apple: New Yorkers can expect to live longer than ever before, and longer even than our fellow Americans, on average. The life expectancy for a baby born in 2009 has risen to an impressive 80.6 years, while the national average is 78.2-years.

Some good news for residents of the Big Apple: New Yorkers can expect to live longer than ever before, and longer even than our fellow Americans, on average. The life expectancy for a baby born in 2009 has risen to an impressive 80.6 years, while the national average is 78.2-years.

Watershed in MS treatment progress

By ACSH Staff — Dec 29, 2011
It used to be that a person diagnosed with multiple sclerosis (MS) was often subject to the dismal prognosis of a gradually but inexorably progressive disease. But developments over recent years are starting to change that outlook. New and more sophisticated drugs have been approved, and more are currently in Phase 3 clinical trials. So, patients with MS can now be more optimistic abut their future than ever before. As Dr.

It used to be that a person diagnosed with multiple sclerosis (MS) was often subject to the dismal prognosis of a gradually but inexorably progressive disease. But developments over recent years are starting to change that outlook. New and more sophisticated drugs have been approved, and more are currently in Phase 3 clinical trials. So, patients with MS can now be more optimistic abut their future than ever before. As Dr.

Drug shortages take a surprising twist

By ACSH Staff — Dec 28, 2011
As ACSH s Dr. Josh Bloom notes in his latest blog post for Medical Progress Today, In the past year, much has been written about the shortage of critical generic drugs in this country. Now, though, there is a shortage of a very different kind of drug. Sodium thiopental, one of the three drugs typically used in lethal injections, which the U.S. purchases almost exclusively from European manufacturers, is no longer being sold.

As ACSH s Dr. Josh Bloom notes in his latest blog post for Medical Progress Today, In the past year, much has been written about the shortage of critical generic drugs in this country. Now, though, there is a shortage of a very different kind of drug. Sodium thiopental, one of the three drugs typically used in lethal injections, which the U.S. purchases almost exclusively from European manufacturers, is no longer being sold.

Cocooning to protect the herd of newborns

By ACSH Staff — Dec 28, 2011
Babies have to wait until they re at least six weeks old to get the DTaP vaccine, which protects them from tetanus, diphtheria, and pertussis (whooping cough). Thus, during these early weeks of life, their undeveloped immune systems make them especially vulnerable to these illnesses. However, the family members who surround these infants can effectively shield them from these diseases by making sure that they themselves have been inoculated.

Babies have to wait until they re at least six weeks old to get the DTaP vaccine, which protects them from tetanus, diphtheria, and pertussis (whooping cough). Thus, during these early weeks of life, their undeveloped immune systems make them especially vulnerable to these illnesses. However, the family members who surround these infants can effectively shield them from these diseases by making sure that they themselves have been inoculated.

Announcing the top ten unfounded health scares of 2011

By ACSH Staff — Dec 27, 2011
ACSH is proud to announce the latest installment of its annual publication, The Top Ten Unfounded Health Scares. Before we officially ring in 2012, we d like to reflect on the most popularized yet most inaccurate health scares of the past year. From Dr. Oz s nonsense arsenic and apple juice scare to unfounded fears of eating supposedly contaminated Gulf seafood, ACSH debunks these allegations and more. Click here for the full list.

ACSH is proud to announce the latest installment of its annual publication, The Top Ten Unfounded Health Scares. Before we officially ring in 2012, we d like to reflect on the most popularized yet most inaccurate health scares of the past year. From Dr. Oz s nonsense arsenic and apple juice scare to unfounded fears of eating supposedly contaminated Gulf seafood, ACSH debunks these allegations and more. Click here for the full list.

Dr. Gottlieb on the future of big pharma

By ACSH Staff — Dec 27, 2011
ACSH friend and former FDA Assistant Commissioner Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute, writes about the trials and tribulations of current pharmaceutical R&D in a new op-ed for the Wall Street Journal.

ACSH friend and former FDA Assistant Commissioner Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute, writes about the trials and tribulations of current pharmaceutical R&D in a new op-ed for the Wall Street Journal.